Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics.

Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics.

SUMMARY: Advances in cDNA and monoclonal antibody technology in the 1980s fuelled the discovery and characterization of the properties of cytokines. It became apparent that because cytokines were expressed in tissues derived from autoimmune diseases, they were likely to be of fundamental importance...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Feldmann, M, Maini, SR
Format:	Journal article
Język:	English
Wydane:	2008

Podobne zapisy

Role of cytokines in rheumatoid arthritis.
od: Feldmann, M, i wsp.
Wydane: (1996)

The role of cytokines in the pathogenesis of rheumatoid arthritis.
od: Feldmann, M, i wsp.
Wydane: (1999)

Cytokine therapy in rheumatoid arthritis.
od: Maini, R, i wsp.
Wydane: (1996)

Role of pro-inflammatory cytokines in rheumatoid arthritis.
od: Brennan, F, i wsp.
Wydane: (1998)

Cytokine expression in rheumatoid arthritis.
od: Brennan, F, i wsp.
Wydane: (1991)

Cytokine blockade in rheumatoid arthritis.
od: Feldmann, M, i wsp.
Wydane: (2001)

From the laboratory to the clinic: Evaluation of cytokines in rheumatoid arthritis highlights TNF-alpha as a new therapeutic target
od: Feldmann, M, i wsp.
Wydane: (1994)

Gene therapy of rheumatoid arthritis via cytokine regulation: future perspectives.
od: Chernajovsky, Y, i wsp.
Wydane: (1995)

Analysis of cytokine expression in rheumatoid synovium has provided new insights into the pathogenesis of rheumatoid arthritis and new therapeutic opportunities.
od: Feldmann, M, i wsp.
Wydane: (2001)

The cytokine network in rheumatoid arthritis: definition of TNF alpha as a therapeutic target.
od: Feldmann, M
Wydane: (1996)

Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair.
od: Chu, C, i wsp.
Wydane: (1992)

Role of HLA class II and cytokine expression in rheumatoid arthritis.
od: Feldmann, M, i wsp.
Wydane: (1988)

Evaluation of the role of cytokines in autoimmune disease: the importance of TNF alpha in rheumatoid arthritis.
od: Feldmann, M, i wsp.
Wydane: (1992)

TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases
od: Feldmann, M, i wsp.
Wydane: (2003)

Anti-cytokine therapy for rheumatoid arthritis.
od: Maini, R, i wsp.
Wydane: (2000)

Rheumatoid arthritis: introduction.
od: Feldmann, M, i wsp.
Wydane: (1998)

Rheumatoid arthritis.
od: Feldmann, M, i wsp.
Wydane: (1996)

TNF alpha is an effective therapeutic target for rheumatoid arthritis.
od: Feldmann, M, i wsp.
Wydane: (1995)

TNF alpha as a therapeutic target in rheumatoid arthritis.
od: Feldmann, M, i wsp.
Wydane: (1994)

Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies.
od: Feldmann, M, i wsp.
Wydane: (2002)

Discovery of TNF-α as a therapeutic target in rheumatoid arthritis: Preclinical and clinical studies
od: Feldmann, M, i wsp.
Wydane: (2002)

TNFα - A pivotal role in rheumatoid arthritis?
od: Brennan, F, i wsp.
Wydane: (1992)

TNF alpha--a pivotal role in rheumatoid arthritis?
od: Brennan, F, i wsp.
Wydane: (1992)

The role of TNF alpha and IL-1 in rheumatoid arthritis.
od: Feldmann, M, i wsp.
Wydane: (2001)

Immunoregulatory role of interleukin 10 in rheumatoid arthritis.
od: Katsikis, P, i wsp.
Wydane: (1994)

Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
od: Williams, R, i wsp.
Wydane: (2007)

Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.
od: Maini, R, i wsp.
Wydane: (1999)

How does infliximab work in rheumatoid arthritis?
od: Maini, R, i wsp.
Wydane: (2002)

Role of cytokines in the pathogenesis of rheumatoid arthritis
od: Aleksandr Aleksandrovich Novikov, i wsp.
Wydane: (2010-04-01)

Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.
od: Feldmann, M, i wsp.
Wydane: (2003)

Rheumatoid arthritis: Pathogenic mechanisms and therapeutic targets
od: Taylor, P, i wsp.
Wydane: (2004)

Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.
od: Feldmann, M, i wsp.
Wydane: (1995)

Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis.
od: Sebbag, M, i wsp.
Wydane: (1997)

Molecular therapeutic targets in rheumatoid arthritis.
od: Sacre, S, i wsp.
Wydane: (2005)

Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis.
od: Hermann, J, i wsp.
Wydane: (1998)

Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets
od: Alessia Alunno, i wsp.
Wydane: (2017-11-01)

Updates on the Pathophysiology and Therapeutic Potential of Extracellular Vesicles with Focus on Exosomes in Rheumatoid Arthritis
od: Gavriilidi IK, i wsp.
Wydane: (2024-07-01)

Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.
od: Charles, P, i wsp.
Wydane: (1999)

ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
od: Feldmann, M, i wsp.
Wydane: (2011)

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
od: Feldmann, M, i wsp.
Wydane: (2001)